Citations

Showing 10 of 108162 citations.

Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data
Ross, Katherine , Kahn, Mazher , Dumkrieger, Gina , Dumkrieger, Gina , Chong, Catherine D. , Berisha, Visar , Schwedt, Todd J.

Mayo Clinic

Cephalalgia | April 30, 2021 | Volume: 41 | Issue: 8 | Pages: 943-955

10.1177/0333102421991819 | PMID 33926241 Get It

Background Persistent post-traumatic headache most commonly has symptoms that overlap those of migraine. In some cases, it can be clinically difficult to differentiate persistent post-traumatic headache with a migraine phenotype from migraine. The objective of this study was to develop a classification model based on questionnaire data and structural neuroimaging data that distinguishes individuals with migraine from those with persistent post-traumatic headache. Methods Questionnaires assessing headache characteristics, sensory hypersensitivities, cognitive functioning, and mood, as well as T1-weighted magnetic resonance imaging and diffusion tensor data from 34 patients with migraine and 48 patients with persistent post-traumatic headache attributed to mild traumatic brain injury were included for analysis. The majority of patients with persistent post-traumatic headache had a migraine/probable migraine phenotype (77%). A machine-learning leave-one-out cross-validation algorithm determined the average accuracy for distinguishing individual migraine patients from individual patients with persistent post-traumatic headache. Results Based on questionnaire data alone, the average classification accuracy for determining whether an individual person had migraine or persistent post-traumatic headache was 71.9%. Adding imaging data features to the model improved the classification accuracy to 78%, including an average accuracy of 97.1% for identifying individual migraine patients and an average accuracy of 64.6% for identifying individual patients with persistent post-traumatic headache. The most important clinical features that contributed to the classification accuracy included questions related to anxiety and decision making. Cortical brain features and fibertract data from the following regions or tracts most contributed to the classification accuracy: Bilateral superior temporal, inferior parietal and posterior cingulate; right lateral occipital, uncinate, and superior longitudinal fasciculus. A post-hoc analysis showed that compared to incorrectly classified persistent post-traumatic headache patients, those who were correctly classified as having persistent post-traumatic headache had more severe physical, autonomic, anxiety and depression symptoms, were more likely to have post-traumatic stress disorder, and were more likely to have had mild traumatic brain injury attributed to blasts. Discussion A classification model that included a combination of questionnaire data and structural imaging parameters classified individual patients as having migraine versus persistent post-traumatic headache with good accuracy. The most important clinical measures that contributed to the classification accuracy included questions on mood. Regional brain structures and fibertracts that play roles in pain processing and pain integration were important brain features that contributed to the classification accuracy. The lower classification accuracy for patients with persistent post-traumatic headache compared to migraine may be related to greater heterogeneity of patients in the persistent post-traumatic headache cohort regarding their traumatic brain injury mechanisms, and physical, emotional, and cognitive symptoms.
Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study
Yousaf, Ahmed , Tjien-Fooh, Félicia , Rentroia‐Pacheco, Barbara , Quattrocchi, Enrica , Kobic, Ajdin, Tempel, Dennie , Meves, Alexander , Meves, Alexander , Kolodney, Michael S.

Mayo Clinic

International Journal of Dermatology | April 29, 2021 | Volume: 60 | Issue: 7 | Pages: 851-856

10.1111/ijd.15594 | PMID 33914348 Get It

AbstractBackgroundApproximately 85% of melanoma patients who undergo a sentinel lymph node biopsy (SLNB) are node‐negative. Melanoma incidence is highest in patients ≥65 years, but their SLNB positivity rate is lower than in younger patients. CP‐GEP, a model combining clinicopathologic and gene expression variables, identifies primary cutaneous melanoma (CM) patients who may safely forgo SLNB due to their low risk for nodal metastasis. Here, we validate CP‐GEP in a U.S. melanoma patient cohort.MethodsA cohort of 208 adult patients with primary CM from the Mayo Clinic and West Virginia University was used. Patients were stratified according to their risk for nodal metastasis: CP‐GEP High Risk and CP‐GEP Low Risk. The main performance measures were SLNB reduction rate (RR) and negative predictive value (NPV).ResultsSLNB positivity rate for the entire cohort was 21%. Most patients had a T1b (34%) or T2a (31%) melanoma. In the T1‐T2 group (153 patients), CP‐GEP achieved an SLNB RR of 41.8% (95% CI: 33.9‐50.1) at an NPV of 93.8% (95% CI: 84.8‐98.3). Subgroup analysis showed similar performance in T1‐T2 patients ≥65 years of age (51 patients; SLNB positivity rate, 9.8%): SLNB RR of 43.1% (95% CI: 29.3‐57.8) at an NPV of 95.5% (95% CI: 77.2‐99.9).ConclusionWe confirmed the potential of CP‐GEP to reduce negative SLNB in all relevant age groups. Our findings are especially relevant to patients ≥65 years, where surgery is often elective. CP‐GEP may guide SLNB decision‐making in clinical practice.
Application of a bioinformatic pipeline to RNA-seq data identifies novel virus-like sequence in human blood
Melnick, Marko , Gonzales, Patrick , LaRocca, Thomas J. , Song, Yuping , Wuu, Joanne , Benatar, Michael , Oskarsson, Björn , Petrucelli, Leonard , Dowell, Robin D. , Link, Christopher D. , Prudencio, Mercedes , Prudencio, Mercedes , Oskarsson, Björn

Mayo Clinic

G3 Genes|Genomes|Genetics | April 29, 2021 | Volume: 11 | Issue: 9 | Pages: No page available

10.1093/g3journal/jkab141 | PMID 33914880 Get It

Abstract Numerous reports have suggested that infectious agents could play a role in neurodegenerative diseases, but specific etiological agents have not been convincingly demonstrated. To search for candidate agents in an unbiased fashion, we have developed a bioinformatic pipeline that identifies microbial sequences in mammalian RNA-seq data, including sequences with no significant nucleotide similarity hits in GenBank. Effectiveness of the pipeline was tested using publicly available RNA-seq data and in a reconstruction experiment using synthetic data. We then applied this pipeline to a novel RNA-seq dataset generated from a cohort of 120 samples from amyotrophic lateral sclerosis patients and controls, and identified sequences corresponding to known bacteria and viruses, as well as novel virus-like sequences. The presence of these novel virus-like sequences, which were identified in subsets of both patients and controls, were confirmed by quantitative RT-PCR. We believe this pipeline will be a useful tool for the identification of potential etiological agents in the many RNA-seq datasets currently being generated.
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors
Bornschlegl, Svetlana, Gustafson, Michael P. , Delivanis, Danae A. , Ryder, Mabel , Liu, Minetta C. , Vasmatzis, George , Hallemeier, Chris L., Roberts, Lewis R. , Jelinek, Diane F., Dietz, Allan B. , Roberts, Lewis R , Dietz, Allan B , Ryder, Mabel , Park, Sean S. , Parney, Ian F.

Mayo Clinic

Clinical & Translational Immunology | April 29, 2021 | Volume: 10 | Issue: 4 | Pages: No page available

10.1002/cti2.1267 | PMID 33968403 Get It

AbstractObjectivesInhibitors to the checkpoint proteins cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) and programmed cell death protein 1 (PD‐1) are becoming widely used in cancer treatment. However, a lack of understanding of the patient response to treatment limits accurate identification of potential responders to immunotherapy.MethodsIn this study, we assessed the expression of PD‐1 and CTLA‐4 on 19 leucocyte populations in the peripheral blood of 74 cancer patients. A reference data set for PD‐1 and CTLA‐4 was established for 40 healthy volunteers to determine the normal expression patterns for these checkpoint proteins.ResultsUnsupervised hierarchical clustering found four immune profiles shared across the solid tumor types, while chronic lymphocytic leukaemia patients had an immune profile largely unique to them. Furthermore, we measured these leucocyte populations on an additional cohort of 16 cancer patients receiving the PD‐1 inhibitor pembrolizumab in order to identify differences between responders and non‐responders, as well as compared to healthy volunteers (n = 20). We observed that cancer patients had pre‐treatment PD‐1 and CTLA‐4 expression on their leucocyte populations at different levels compared to healthy volunteers and identified two leucocyte populations positive for CTLA‐4 that had not been previously described. We found higher levels of PD‐1+ CD3+ CD4− CD8− cells in patients with progressive disease and have identified it as a potential biomarker of response, as well as identifying other significant differences in phenotypes between responders and non‐responders.ConclusionThese results are suggestive that categorisation of patients based on immune profiles may differentiate responders from non‐responders to immunotherapy for solid tumors.
Heeding the call of COVID-19
Wiebers, David O. , Feigin, Valery L.

Mayo Clinic

Animal Sentience | April 29, 2021 | Volume: 5 | Issue: 30 | Pages: No page available

10.51291/2377-7478.1671 Get It

We are grateful to all of our commentators. They have provided a wide range of valuable perspectives and insights from many fields, revealing a broad interest in the subject matter. Nearly all the commentaries have helped to affirm, refine, expand, amplify, deepen, interpret, elaborate, or apply the messages in the target article. Some have offered critiques and suggestions that help us address certain issues in greater detail, including several points concerning industrialized farming and the wildlife trade. Overall, there is great awareness and strong consensus among commentators that any solution for preventing future pandemics and other related health crises must take into account not only what is best for humans but also what is best for nonhumans and the environment, given the profound interconnectedness of all life.
Assessments of Physicians’ Electrocardiogram Interpretation Skill: A Systematic Review
Cook, David A. , Oh, So-Young, Pusic, Martin V., Pusic, Martin , Pusic, Martin V , Cook, D A , Oh, So-Young

Mayo Clinic

Academic Medicine | April 29, 2021 | Volume: 97 | Issue: 4 | Pages: 603-615

10.1097/acm.0000000000004140 | PMID 33913438 Get It

Purpose To identify features of instruments, test procedures, study design, and validity evidence in published studies of electrocardiogram (ECG) skill assessments. Method The authors conducted a systematic review, searching MEDLINE, Embase, Cochrane CENTRAL, PsycINFO, CINAHL, ERIC, and Web of Science databases in February 2020 for studies that assessed the ECG interpretation skill of physicians or medical students. Two authors independently screened articles for inclusion and extracted information on test features, study design, risk of bias, and validity evidence. Results The authors found 85 eligible studies. Participants included medical students (42 studies), postgraduate physicians (48 studies), and practicing physicians (13 studies). ECG selection criteria were infrequently reported: 25 studies (29%) selected single-diagnosis or straightforward ECGs; 5 (6%) selected complex cases. ECGs were selected by generalists (15 studies [18%]), cardiologists (10 studies [12%]), or unspecified experts (4 studies [5%]). The median number of ECGs per test was 10. The scoring rubric was defined by 2 or more experts in 32 studies (38%), by 1 expert in 5 (6%), and using clinical data in 5 (6%). Scoring was performed by a human rater in 34 studies (40%) and by computer in 7 (8%). Study methods were appraised as low risk of selection bias in 16 studies (19%), participant flow bias in 59 (69%), instrument conduct and scoring bias in 20 (24%), and applicability problems in 56 (66%). Evidence of test score validity was reported infrequently, namely evidence of content (39 studies [46%]), internal structure (11 [13%]), relations with other variables (10 [12%]), response process (2 [2%]), and consequences (3 [4%]). Conclusions ECG interpretation skill assessments consist of idiosyncratic instruments that are too short, composed of items of obscure provenance, with incompletely specified answers, graded by individuals with underreported credentials, yielding scores with limited interpretability. The authors suggest several best practices.
Development of a Decellularized Porcine Esophageal Matrix for Potential Applications in Cancer Modeling
Chaitin, Hersh , Lu, Michael L. , Wallace, Michael B. , Kang, Yunqing , Wallace, Michael B

Mayo Clinic

Cells | April 29, 2021 | Volume: 10 | Issue: 5 | Pages: 1055

10.3390/cells10051055 | PMID 33946915 Get It

Many decellularized extracellular matrix-derived whole organs have been widely used in studies of tissue engineering and cancer models. However, decellularizing porcine esophagus to obtain decellularized esophageal matrix (DEM) for potential biomedical applications has not been widely investigated. In this study a modified decellularization protocol was employed to prepare a porcine esophageal DEM for the study of cancer cell growth. The cellular removal and retention of matrix components in the porcine DEM were fully characterized. The microstructure of the DEM was observed using scanning electronic microscopy. Human esophageal squamous cell carcinoma (ESCC) and human primary esophageal fibroblast cells (FBCs) were seeded in the DEM to observe their growth. Results show that the decellularization process did not cause significant loss of mechanical properties and that blood ducts and lymphatic vessels in the submucosa layer were also preserved. ESCC and FBCs grew on the DEM well and the matrix did not show any toxicity to cells. When FBS and ESCC were cocultured on the matrix, they secreted more periostin, a protein that supports cell adhesion on matrix. This study shows that the modified decellularization protocol can effectively remove the cell materials and maintain the microstructure of the porcine esophageal matrix, which has the potential application of studying cell growth and migration for esophageal cancer models.
Synthesis and properties of magnetite nanoparticles with peroxide‐containing polymer shell and nanocomposites based on them
Serdiuk, Vitalii , Shevchuk, Oleh , Bukartyk, Natalya, Kovalenko, Tetiana , Borysiuk, Anatoliy , Tokarev, Viktor , Bukartyk, N. M. , Kovalenko, Tetiana

Mayo Clinic

Journal of Applied Polymer Science | April 29, 2021 | Volume: 138 | Issue: 36 | Pages: No page available

10.1002/app.50928 Get It

AbstractMagnetite nanoparticles (Fe3O4 NPs) with peroxide‐containing polymer shell have been synthesized using the method of coprecipitation from the mixture solutions of Fe (II) and Fe (III) salts in the presence of peroxide‐containing copolymer (PCC). Polymer shell presence has been proved by elemental and complex thermal analysis. Synthesized Fe3O4 NPs possess superparamagnetic properties. Their specific saturation magnetization decreases gradually from 65 to 54 A·m2·kg−1 with increasing PCC concentration owing to the surface spin pinning effect caused by a polymer shell. The average sizes of Fe3O4 NPs estimated from the data of XRD analysis and magnetic measurements are in the range of 9–12 nm. The NP sizes determined by the DLS method lie in the range of 150–270 nm; this result is significantly larger than the sizes estimated by the two aforementioned methods evidencing a tendency for Fe3O4 NPs toward self‐association. Cross‐linked composite films based on polyvinyl alcohol have been obtained via radical curing initiated by the PCC shell of nanoparticles. The resulting composite films are magnetically sensitive films with rather high physico‐mechanical properties (tensile strength reaches 48–67 MPa and relative elongation – 4%–21% depending on cross‐linking degree), a priori non‐toxic and biocompatible, which makes them promising materials for various applications.
Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration
Saffari, Tiam M. , Chan, Katelyn, Saffari, Sara , Zuo, Kevin J. , McGovern, Renee M., Shin, Alexander Y. , Chan, K. Ming , Reid, Joel M. , Shin, Alexander Y , Chan, Katelyn, Borschel, Gregory Howard

Mayo Clinic

Biotechnology and Bioengineering | April 29, 2021 | Volume: 118 | Issue: 7 | Pages: 2804-2814

10.1002/bit.27799 | PMID 33913523 Get It

AbstractThe application of scaffold‐based stem cell transplantation to enhance peripheral nerve regeneration has great potential. Recently, the neuroregenerative potential of tacrolimus (a U.S. Food and Drug Administration‐approved immunosuppressant) has been explored. In this study, a fibrin gel‐based drug delivery system for sustained and localized tacrolimus release was combined with rat adipose‐derived mesenchymal stem cells (MSC) to investigate cell viability in vitro. Tacrolimus was encapsulated in poly(lactic‐co‐glycolic) acid (PLGA) microspheres and suspended in fibrin hydrogel, using concentrations of 0.01 and 100 ng/ml. Drug release over time was measured. MSCs were cultured in drug‐released media collected at various days to mimic systemic exposure. MSCs were combined with (i) hydrogel only, (ii) empty PLGA microspheres in the hydrogel, (iii) 0.01, and (iv) 100 ng/ml of tacrolimus PLGA microspheres in the hydrogel. Stem cell presence and viability were evaluated. A sustained release of 100 ng/ml tacrolimus microspheres was observed for up to 35 days. Stem cell presence was confirmed and cell viability was observed up to 7 days, with no significant differences between groups. This study suggests that combined delivery of 100 ng/ml tacrolimus and MSCs in fibrin hydrogel does not result in cytotoxic effects and could be used to enhance peripheral nerve regeneration.